Gayatri BioOrganics will hold its 35th Annual General Meeting on September 23, 2026. The meeting agenda includes a proposed name change to Ananth BioOrganics Limited and a leadership restructuring.

The company reported a net loss of ₹111.18 lakh for FY26, an increase from the ₹72.65 lakh loss recorded in FY25. Revenue from operations remained at zero for both periods.

Corporate Restructuring

Shareholders are being asked to approve a special resolution to change the company’s name from Gayatri BioOrganics Limited to Ananth BioOrganics Limited. The board stated this move aims to reflect new ownership, management structure, and future business objectives without altering the main objects or nature of the business.

Additionally, members are sought to approve the change in designation of Mr. Sreedhara Reddy Kanaparthi from Whole-time Director to Chairman and Managing Director. This appointment is effective from August 5, 2026, for a three-year term initially without remuneration.

Financial Performance

The company did not generate any revenue during FY26 or FY25. The widening loss was driven by higher finance costs and other expenses.

Total assets stood at ₹171.75 lakh as on March 31, 2026, compared to ₹166.35 lakh in the previous year. Borrowings increased significantly, with non-current borrowings rising to ₹3,523.14 lakh from ₹349.73 lakh.

What the Numbers Show

The surge in borrowings contrasts sharply with the absence of operating revenue. Non-current borrowings grew nearly tenfold year-on-year, while the company continued to report zero income from operations. This indicates that the increase in debt was not funded by operational cash flows but likely through external financing or related-party loans, as noted in the balance sheet disclosures regarding loans from directors and other entities.

Governance Updates

The AGM will also see the re-appointment of Mr. Sreedhara Reddy Kanaparthi as a director. The company has adopted new Memorandum and Articles of Association to align with the Companies Act, 2013. Two independent directors, Mr. Ramachandra Seshaprasad Chodavarapu and Mr. Murali Vittala, resigned during the year citing advancing age, while Mr. Srinivas Iduri was appointed as an independent director.

Gayatri BioOrganics Limited has accepted the resignation of Venkata Sandeep Kumar Reddy Tikkavarapu from his positions as Chairman and Non-Executive Director. The resignation takes effect on August 5, 2026, following a letter dated August 4, 2026, in which Reddy cited professional responsibilities and personal reasons for stepping down. This leadership change impacts the governance structure of the Hyderabad-based agri-inputs company, requiring the Board to address the vacancy in its upcoming proceedings.

The resignation also covers Reddy’s membership in all board committees. In his resignation letter, Reddy requested that the company acknowledge receipt and submit the necessary forms to the office of the Registrar of Companies (ROC) and the relevant Stock Exchanges to formalize the change. The Board of Directors has confirmed acceptance of these terms.

Key Details of Resignation

Venkata Sandeep Kumar Reddy Tikkavarapu holds DIN 00005573. His departure marks a significant shift in the company’s senior management team. The company is expected to initiate the process of appointing a new Chairman and potentially other directors to fill the resulting vacancies in accordance with regulatory requirements.

Governance Implications

The resignation necessitates immediate attention from the Board regarding succession planning. As the outgoing Chairman, Reddy’s exit may influence ongoing strategic initiatives and committee-level oversight until a successor is appointed. The company must ensure compliance with listing regulations concerning the timely disclosure of such changes and the filing of requisite forms with market regulators.

No financial metrics were disclosed in relation to this personnel change. The focus remains on the procedural aspects of the transition and the subsequent steps required to maintain effective corporate governance at Gayatri BioOrganics Limited.